Mayo Clinic Cancer Center and Yale Cancer Center/Smilow Cancer Hospital Named Newest NCCN Member Institutions
Mayo Clinic Cancer Center and Yale Cancer Center/Smilow Cancer Hospital have been named the newest NCCN Member Institutions; NCCN now has 25 Member Institutions serving patients throughout the United States. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®), an alliance of the world`s leading cancer centers dedicated to the quality, effectiveness, and efficiency of care provided to people with cancer, announced today the addition of two new NCCN Member Institutions: M... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 19, 2014 Category: Cancer & Oncology Source Type: news

Nccn 19
The NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™ will take place on March 13 - 15, 2014 in Hollywood, Florida; The 2014 conference features two expert roundtable discussions and clinical treatment updates for more than 15 disease types. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) will hold the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™, March 13 - 15, 2014, at The Westin Diplomat in Hollywood, Florida. Approximatel... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 12, 2014 Category: Cancer & Oncology Source Type: news

NCCN and the Affordable Care Act
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 28, 2014 Category: Cancer & Oncology Source Type: news

"Addition of Bevacizumab to the Treatment of Newly Diagnosed Glioblastoma Brain Tumors Does Not Extend Patients’ Lives," Healthcanal.com
This study was led by representatives from The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute and The University of Texas MD Anderson Cancer Center - two of the 23 NCCN Member Insti... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 25, 2014 Category: Cancer & Oncology Source Type: news

“Dismantling Pancreas Cancer’s Armor,” Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Pancreas cancer is notoriously impervious to treatment and resists both chemotherapy and radiotherapy. It has also been thought to provide few targets for immune cells, allowing tumors to grow unchecked. But, new research from Fred Hutchinson Cancer Research Center shows that pancreas cancer "veils" itself from the immune system by recruiting specialized immune suppressor cells. The research team also found that removing these cells quickly triggers a spontaneous anti-tumor immune response. Fre... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 20, 2014 Category: Cancer & Oncology Source Type: news

“Cancer Immunotherapy Treatment Shows More Promise,”
A technique to genetically modify a patient`s own immune cells eradicated tumors in 14 of 16 patients with advanced leukemia-at least for a time-in a study that adds to growing enthusiasm for efforts to enlist the body`s immune system in the fight against cancer. The findings, from researchers at Memorial Sloan-Kettering Cancer Center, also add fuel to an emerging race to bring new so-called cancer immunotherapy treatments to the market. Juno Therapeutics Inc., a Seattle startup, is preparing t... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 19, 2014 Category: Cancer & Oncology Source Type: news

“Women, Doctors Try to Make Sense of Study on Mammograms”,
This article features commentary from a representative of Memorial Sloan-Kettering Can... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 19, 2014 Category: Cancer & Oncology Source Type: news

"New Test Suggests Antidepressant Paxil May Promote Breast Cancer,"
A team of researchers from City of Hope Comprehensive Cancer Center - one of the 23 NCCN Member Institutions - has developed a speedy way to identify drugs and chemicals that can disrupt the balance of sex hormones in human beings and influence the development and progress of diseases such as breast cancer.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 18, 2014 Category: Cancer & Oncology Source Type: news

"Johns Hopkins Experts Identify Major Sources of High Cancer Costs," News-medical.net
In a review article published February 14, 2014 in The Lancet Oncology, Johns Hopkins experts identify three major sources of high cancer costs and argue that cancer doctors can likely reduce them without harm to patients. The cost-cutting proposals call for changes in routine clinical practice involved in end-of-life care, medical imaging, and drug pricing. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 17, 2014 Category: Cancer & Oncology Source Type: news

“Double Mastectomy May Benefit Some Women with Inherited Breast Cancer“, Fox Chase Cancer Center
This article features commentary from a representative at Fox Chase Cancer Center - one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 12, 2014 Category: Cancer & Oncology Source Type: news

“Gene Exam Might Predict Breast Cancer Progression”, Philly.com
This article features commentary from a representative of City of Hope Comprehensive Cancer Center-one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 11, 2014 Category: Cancer & Oncology Source Type: news

NCCN Affiliate Research Consortium Offers Community Cancer Centers Cutting-Edge Research Opportunities
The NCCN Oncology Research Program (ORP) has established the NCCN Affiliate Research Consortium (ARC) to maximize collaboration between the NCCN Member Institutions and their affiliate research investigators. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has established the NCCN Affiliate Research Consortium (ARC). The NCCN ARC`s primary goal is to maximize collaboration between NCCN Member Institutions and their affiliate research ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 8, 2014 Category: Cancer & Oncology Source Type: news

"Peter B. Bach Discusses New Payment Reform Models Challenging Fee for Service," OBR Oncology Online
In the debate whether Patient Centered Medical Homes and Accountable Care Organizations will lead to health care system savings, Peter B. Bach, MD, MAPP, Director, Center for Health Policy and Outcomes, Memorial Sloan-Kettering Cancer Center, discussed at a recent conference how new payment models are challenging the current fee-for-service model for community care cancer centers. Memorial Sloan-Kettering Cancer Center is one of the 23 NCCN Member Institutions.... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 1, 2014 Category: Cancer & Oncology Source Type: news

Margaret A. Tempero, MD, Named Editor-in-Chief of
JNCCN - Journal of the National Comprehensive Cancer Network named Margaret A. Tempero, MD, UCSF Helen Diller Family Comprehensive Cancer Center, as the new Editor-in-Chief, succeeding Harold J. Burstein, MD, PhD, who served in the position for five years. FORT WASHINGTON, PA - JNCCN - Journal of the National Comprehensive Cancer Network, the official journal of the National Comprehensive Cancer Network® (NCCN®),has named Margaret A. Tempero, MD, as Editor-in-Chief. Dr. Tempero will assume... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - January 26, 2014 Category: Cancer & Oncology Source Type: news

NCCN Appoints Gary Weyhmuller as Chief Operating Officer
Gary Weyhmuller, MBA, will join NCCN as Executive Vice President and Chief Operating Officer on February 3, 2014. Formerly, Mr. Weyhmuller served as Senior Vice President and Chief Operating Officer at Fox Chase Cancer Center. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 23 of the world`s leading cancer centers dedicated to improving the quality, effectiveness, and efficiency of cancer care, has appointed Gary Weyhmuller, MBA, as Exe... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - January 18, 2014 Category: Cancer & Oncology Source Type: news